Vaccination and Immunization

>

Latest News

FDA clears investigational NDA for VAX-31 to prevent invasive pneumococcal disease | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA clears investigational NDA for VAX-31 to prevent invasive pneumococcal disease

November 12th 2024

The initiation of a phase 2 study of the investigational 31-valent pneumococcal conjugate vaccine is expected by the end of January 2025.

MenACWY program associated with reduced invasive meningococcal disease among adolescentsLatest revision | Image Credit: © Generative AI - © Generative AI - stock.adobe.com.
MenACWY program associated with reduced invasive meningococcal disease among adolescents

November 7th 2024

Typical RSV vaccine uptake could lead to few pediatric ICU encounters | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com.
Typical RSV vaccine uptake could lead to fewer pediatric ICU encounters

October 28th 2024

Office preparation for fall vaccine administration: Are you ready? | Image Credit: © REDPIXEL - © REDPIXEL - stock.adobe.com.
Office preparation for fall vaccine administration: Are you ready?

October 24th 2024

ACIP recommends ≥1 updated COVID-19 vaccine booster for all children, adolescents
ACIP recommends ≥1 updated COVID-19 vaccine booster for all children, adolescents

September 11th 2024

More News

Site Logo

The 2003 immunization schedule: Read the fine print

January 1st 2003

Site Logo

Editorial: Childhood immunization: Read the fine print

Julia A. McMillan, MD
February 1st 2002

Keeping track of changes in immunization recommendations is the best way to be certain that our patients receive maximal benefit.

Site Logo

Drug Therapy: What's new in the 2001 immunization schedule

January 1st 2001

The biggest change in this year's schedule is the addition of the seven-valent pneumococcal conjugate vaccine.

Site Logo

When parents resist immunizations

Magna Chang Dias;Edgar K Marcuse
July 1st 2000

Many families feel that pediatricians just don't listen when they try to voice concerns about vaccines. Our recommendation: Identify each family's specific issues, target your response accordingly, and use a nonconfrontational approach. Time-consuming lectures on big subjects like immunology generally aren't needed.

<1
...
89101112
© 2024 MJH Life Sciences

All rights reserved.